2 Milliarden $: Patriot Scientific gegen intel

bereits der vierte  Lizenznehmer in diesem Monat. Bei dem Tempo haben wir bald mehr Cash
auf dem Konto als Börsenbewertung.Aber ich kann warten.  

dann immer noch einige trottel für um einen dollar ihre anteile?  

sind noch nicht alle verkauft - sind sie es mal, steigt der Kurs auch wieder.

Ich kann auch warten. Wüsste zu gerne den Umsatz von Pentax - nirgendwo eine Info dazu, Mist.
 

angestrebte Verkaufspreis:

 

wenn die möglichkeit besteht das ganze auch bei 5oder 8$ durchzuziehen?
das kapier ich nicht!  

Ich glaube es wird schwer, 22 Mio. Aktien zu 5 oder 8 USD zu verkaufen. Irendwie scheint der Verkaufsdruck für heute etwas weg zu sein - vielleicht ist ja auch schon alles verkauft. Mal sehen....

Schönen Feierabend Abenteurer  

hoffe ihr schliesst heute nicht im minus

aber 1 trost bleibt ja,,es werden heute keine 10%minus,,,,


aber dafür morgen?pder übermorgen?  

soviel zum Thema bin ich froh da ich alles verkauft hab


greets fussi  

Löchern gekrochen. Langsam kommt mir wieder der Gedanke, diesen Thead zu schließen und einen neuen aufzumachen. Dann muss ich diese Pseudoklugscheißerei nicht länger ertragen. Leute, Leute, was bringt Euch das denn? Lebt Euren Sozialneid doch lieber anders aus: Klebt einen Aufkleber mit "Mich kotzt Eure Armut an" an den geleasten Maibach!

Abenteurer

 

 

lass sie doch quatschen, den sie wissen nicht was sie tun.



Oder mal direkt an die Basher:



Wenn man keine Ahnung hat...





























... einfach mal die Fresse halten.





 

jetzt steinigst du jeden, der dir auf dem Weg steht. Und dies an so einem schönen Tag. Deine Verärgerung wegen den Zocker ist verständlich.

Ich hoffe dich morgen in einer besseren Laune hier anzutreffen.

lg
o  

gar nicht lesen können.;-))

Ansonsten würde man verstehen was dieser Satz bedeutet.

"As the First Round MMP Portfolio licensing berths in many industry sectors are being captured, royalty rates are increasing according to plan."

Aber is scho recht...denkt weiter kurzfristig bei diesem Wert und versucht diesen schräd mit euren rudimentären Kenntnissen vollzumüllen.

Eines werdet ihr nicht ändern, das ich ALLE meine shares behalte.

Einen wunderschönen Abend und skol

greetz joker

 

 

geschätzter Moderator Reab hält diese Pöbeleien für zulässig und sieht keinen Grund etwas zu veranlassen. Wenn das so ist, brauchen wir auch keine Moderatoren mehr.
Armes Ariva, noch ärmerer Reab.  

mal das unser Pohl an was ganz großem arbeitet, denn der Stillstand des
Kurse auf diese Niveau und bei der Nachrichtenlage ist nicht normal zumal die Lizensierungsabstände verschwindend gering werden, so sollte am Freitag die Nächste folgen (vielleicht IBM das kocht eh schon lange im Hintergrund).

Mal Meinungen dazu

greets fussi  

auszusetzen.

Einzig allein der Kurs macht noch nicht so mit wie wir uns das alle wünschen und das wird einen Grund haben, den wir nicht erfahren werden.

Ob es das buyback Programm ist oder ein Verkauf von Aktien , weil ein Teil Kasse macht und nicht warten will,oder, oder, oder...

Ich kann nur für mich sprechen und sagen,das ich weiterhin von PTSC überzeugt bin und das es nur eine Frage der Zeit ist wenn der Kurs dies auch widerspiegelt.

greetz joker  

Sorry aber das musste mal raus. Bin heute viel besser gelaunt.

Also allen eine schönen Tag,
Abenteurer  

Patriot Scientific Confirms PENTAX Joins Growing Roster of Global Manufacturers Licensed to Use the Moore Microprocessor Patent(TM) Portfolio


PENTAX Becomes Seventh Major System Manufacturer During 2006 to Purchase
Rights to Use Fundamental MMP Portfolio Technologies

CARLSBAD, Calif., June 29 /PRNewswire-FirstCall/ -- Patriot Scientific
Corporation (OTC Bulletin Board: PTSC) confirmed today that PENTAX
Corporation has agreed to purchase, pending approval by its board, a
license to use the Moore Microprocessor Patent(TM) (MMP) Portfolio. Six
other major system manufacturers have purchased MMP licenses this year.
Prior licensees include HP, Casio, Fujitsu, Sony and Nikon as well as Seiko
Epson, whose board approved this week its earlier-announced agreement to
purchase an MMP license.
Patriot Scientific and The TPL Group are co-owners of the MMP
Portfolio, which Alliacense(TM), a TPL Group enterprise, exclusively
manages. The MMP Portfolio patents, filed in the 1980s, cover techniques
that have become essential to consumer and commercial digital systems
ranging from DVD players, cell phones and portable music players, to
communications infrastructure, medical equipment and automobiles.
"We are delighted to confirm that PENTAX is the fourth global leader to
agree to purchase an MMP license this month," said David Pohl, Patriot
Scientific chairman and CEO. "This further demonstrates that our MMP
licensing program is strong and gaining momentum as well as increasing the
mounting evidence of the strength of our jointly owned patent portfolio."
He confirmed that latest reports from the licensing team indicate that now
some 300 companies have been put on notice of likely infringement of one or
more patents included in the MMP portfolio.
"Our roster of MMP Portfolio licensees is beginning to look like the
\'Who\'s Who\' in the world of Intellectual Property," said Mac Leckrone,
Alliacense president. "PENTAX along with prior licensees are each in their
own right leading developers of intellectual property; and it is therefore
gratifying to have them quickly recognize the import of the fundamental
technologies protected by the MMP Portfolio."
Leckrone announced that as the first-round MMP Portfolio licensing
berths in many industry sectors are being captured, license rates are
increasing according to plan. At this stage of the licensing program, the
licensing group is continuing to focus on industry leaders whose management
is empowered to make quick strategic business decisions.
"This is another event demonstrating that Patriot Scientific has
successfully completed its exciting transition within the past year to
become a profitable company whose primary revenues are currently based upon
licenses of our valuable intellectual property," said Pohl. "In this
remarkable period, we not only retired our last remaining convertible
debentures to eliminate long-term debt, but we also rocked the world of
microcap companies during this past fiscal quarter by the virtually
unprecedented action of paying a cash dividend to shareholders -- not just
once, but twice within a period of six weeks."
Pohl applauded the licensing team for having produced seven licensing
agreements in the first six months of 2006. He noted that this remarkable
level of success has produced advice from Patriot\'s attorneys and
independent accountants that licenses are no longer extraordinary events
for the company for which notice and information on Form 8-K must be filed
with the SEC each time a license agreement is signed. Now that, in most
instances, the requirements to file notices of license events with the SEC
no longer apply, the result is that various contractual confidentiality
clauses are now fully applicable and that exceptions to such agreements
that were related to the SEC filing requirements are no longer available to
the company.
"This means that the company finds itself in the difficult position of
wanting to share the exciting details of license revenues at the time the
licenses are announced, yet we are legally prevented from doing so," Pohl
stated. "As a result, investors expecting to learn the dollar amounts of
revenues received by Patriot Scientific in connection with recent and
future licenses will find that such information will be available only as
included in regular quarterly financial statements filed by Patriot with
the SEC."
The Patriot Scientific Board of Directors is considering additional
strategic moves intended to enhance the strength and profitability of the
company for the benefit of its shareholders, Pohl added. "As we accumulate
capital resulting from licensing revenues, we are evaluating possible
opportunities to diversify our revenue stream by engaging in joint ventures
or acquiring other companies or technologies compatible with our business
focus -- all depending, of course, upon future revenue and the board\'s
determination of prudent, feasible action in light of available capital and
market conditions at the time," he concluded.
About Patriot Scientific
Patriot Scientific is a leading intellectual property licensing company
that develops, markets and enables innovative technologies to address the
demands in fast-growing markets such as wireless devices, smart cards, home
appliances and gateways, set-top boxes, entertainment technology,
automotive telematics, biomedical devices and industrial controllers.
Headquartered in Carlsbad, Calif., information about the company can be
found at http://www.ptsc.com .
Detailed information about Patriot Scientific can be found at
http://www.ptsc.com . Copies of Patriot Scientific press releases, current
price quotes, stock charts and other valuable information for investors may
be found at http://www.hawkassociates.com and
http://www.americanmicrocaps.com . An investment profile on Patriot
Scientific may be found at
http://www.hawkassociates.com/patriot/profile.php .
About the Patent Portfolio
The patent portfolio, marketed as the Moore Microprocessor Patent
Portfolio, contains intellectual property that is jointly owned by publicly
held Patriot Scientific Corporation and the privately held TPL Group. The
portfolio encompasses seven U.S. patents as well as their European and
Japanese counterparts. Both TPL and Patriot assert that their jointly owned
patents protect techniques used in designing microprocessors,
microcontrollers, Digital Signal Processors (DSPs), embedded processors and
System-on-Chip (SoC) implementations. The MMP Portfolio is exclusively
managed by Alliacense, a TPL Group Enterprise.
About Alliacense
Alliacense is a TPL Group Enterprise executing best-in-class design and
implementation of intellectual property licensing programs. As a cadre of
IP licensing strategists, technology experts and experienced business
development/management executives, Alliacense focuses on expanding the
awareness and value of TPL\'s intellectual property portfolios. For more
information, visit http://www.alliacense.com .
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995: Statements in this news release looking forward in time
involve risks and uncertainties, including the risks associated with the
effect of changing economic conditions, trends in the products markets,
variations in the company\'s cash flow, market acceptance risks, technical
development risks, seasonality and other risk factors detailed in the
company\'s Securities and Exchange Commission filings.
Moore Microprocessor Patent, MMP and Alliacense are trademarks of
Technology Properties Limited (TPL). All other trademarks belong to their
respective owners.
CONTACTS:
Patriot Media Relations
The Hoffman Agency
David Friedman
(303) 868-9641
dfriedman@hoffman.com

Patriot Investor Relations
Hawk Associates
Frank Hawkins or Ken AuYeung
(305) 451-1888
info@hawkassociates.com

Alliacense Media Relations
TPL Group
Tom Rigoli
(650) 969-5986
rigoli@mindpik.com

 

Press Release Source: Patriot Scientific Corporation

Patriot Scientific Confirms PENTAX Joins Growing Roster of Global Manufacturers Licensed to Use the Moore Microprocessor Patent(TM) Portfolio
Thursday June 29, 8:48 am ET  
PENTAX Becomes Seventh Major System Manufacturer During 2006 to Purchase Rights to Use Fundamental MMP Portfolio Technologies


CARLSBAD, Calif., June 29 /PRNewswire-FirstCall/ -- Patriot Scientific Corporation (OTC Bulletin Board: PTSC - News) confirmed today that PENTAX Corporation has agreed to purchase, pending approval by its board, a license to use the Moore Microprocessor Patent(TM) (MMP) Portfolio. Six other major system manufacturers have purchased MMP licenses this year. Prior licensees include HP, Casio, Fujitsu, Sony and Nikon as well as Seiko Epson, whose board approved this week its earlier-announced agreement to purchase an MMP license.
ADVERTISEMENT


Patriot Scientific and The TPL Group are co-owners of the MMP Portfolio, which Alliacense(TM), a TPL Group enterprise, exclusively manages. The MMP Portfolio patents, filed in the 1980s, cover techniques that have become essential to consumer and commercial digital systems ranging from DVD players, cell phones and portable music players, to communications infrastructure, medical equipment and automobiles.

"We are delighted to confirm that PENTAX is the fourth global leader to agree to purchase an MMP license this month," said David Pohl, Patriot Scientific chairman and CEO. "This further demonstrates that our MMP licensing program is strong and gaining momentum as well as increasing the mounting evidence of the strength of our jointly owned patent portfolio." He confirmed that latest reports from the licensing team indicate that now some 300 companies have been put on notice of likely infringement of one or more patents included in the MMP portfolio.

"Our roster of MMP Portfolio licensees is beginning to look like the 'Who's Who' in the world of Intellectual Property," said Mac Leckrone, Alliacense president. "PENTAX along with prior licensees are each in their own right leading developers of intellectual property; and it is therefore gratifying to have them quickly recognize the import of the fundamental technologies protected by the MMP Portfolio."

Leckrone announced that as the first-round MMP Portfolio licensing berths in many industry sectors are being captured, license rates are increasing according to plan. At this stage of the licensing program, the licensing group is continuing to focus on industry leaders whose management is empowered to make quick strategic business decisions.

"This is another event demonstrating that Patriot Scientific has successfully completed its exciting transition within the past year to become a profitable company whose primary revenues are currently based upon licenses of our valuable intellectual property," said Pohl. "In this remarkable period, we not only retired our last remaining convertible debentures to eliminate long-term debt, but we also rocked the world of microcap companies during this past fiscal quarter by the virtually unprecedented action of paying a cash dividend to shareholders -- not just once, but twice within a period of six weeks."

Pohl applauded the licensing team for having produced seven licensing agreements in the first six months of 2006. He noted that this remarkable level of success has produced advice from Patriot's attorneys and independent accountants that licenses are no longer extraordinary events for the company for which notice and information on Form 8-K must be filed with the SEC each time a license agreement is signed. Now that, in most instances, the requirements to file notices of license events with the SEC no longer apply, the result is that various contractual confidentiality clauses are now fully applicable and that exceptions to such agreements that were related to the SEC filing requirements are no longer available to the company.

"This means that the company finds itself in the difficult position of wanting to share the exciting details of license revenues at the time the licenses are announced, yet we are legally prevented from doing so," Pohl stated. "As a result, investors expecting to learn the dollar amounts of revenues received by Patriot Scientific in connection with recent and future licenses will find that such information will be available only as included in regular quarterly financial statements filed by Patriot with the SEC."

The Patriot Scientific Board of Directors is considering additional strategic moves intended to enhance the strength and profitability of the company for the benefit of its shareholders, Pohl added. "As we accumulate capital resulting from licensing revenues, we are evaluating possible opportunities to diversify our revenue stream by engaging in joint ventures or acquiring other companies or technologies compatible with our business focus -- all depending, of course, upon future revenue and the board's determination of prudent, feasible action in light of available capital and market conditions at the time," he concluded.

About Patriot Scientific

Patriot Scientific is a leading intellectual property licensing company that develops, markets and enables innovative technologies to address the demands in fast-growing markets such as wireless devices, smart cards, home appliances and gateways, set-top boxes, entertainment technology, automotive telematics, biomedical devices and industrial controllers. Headquartered in Carlsbad, Calif., information about the company can be found at http://www.ptsc.com .

Detailed information about Patriot Scientific can be found at http://www.ptsc.com . Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com . An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/patriot/profile.php .

About the Patent Portfolio

The patent portfolio, marketed as the Moore Microprocessor Patent Portfolio, contains intellectual property that is jointly owned by publicly held Patriot Scientific Corporation and the privately held TPL Group. The portfolio encompasses seven U.S. patents as well as their European and Japanese counterparts. Both TPL and Patriot assert that their jointly owned patents protect techniques used in designing microprocessors, microcontrollers, Digital Signal Processors (DSPs), embedded processors and System-on-Chip (SoC) implementations. The MMP Portfolio is exclusively managed by Alliacense, a TPL Group Enterprise.

About Alliacense

Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of intellectual property licensing programs. As a cadre of IP licensing strategists, technology experts and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL's intellectual property portfolios. For more information, visit http://www.alliacense.com .

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.

Moore Microprocessor Patent, MMP and Alliacense are trademarks of Technology Properties Limited (TPL). All other trademarks belong to their respective owners.


    CONTACTS:
    Patriot Media Relations
    The Hoffman Agency
    David Friedman
    (303) 868-9641
    dfriedman@hoffman.com

    Patriot Investor Relations
    Hawk Associates
    Frank Hawkins or Ken AuYeung
    (305) 451-1888
    info@hawkassociates.com

    Alliacense Media Relations
    TPL Group
    Tom Rigoli
    (650) 969-5986
    rigoli@mindpik.com




--------------------------------------------------
Source: Patriot Scientific Corporation  

 

Groß und Klein und bringen das Geld vorbei.  

 

Daimler/Chrysler wird es sein. Damit hat man den Bogen von USA bis nach Europa geschlagen.  

das ist ein Wert den man sich ins Depot legt und liegen lässt.

Man kann als Trader auch sein Geld mit dem Wert machen,aber da gibt es sicherlich andere "Zockerwerte" mittlerweile.

PTSC wird mit jeder Lizenzahlung teurer und diejenigen die sich noch nicht durchringen konnten mit PTSC zu verhandeln werden es am Preis spüren.

Die letzten beissen die Hunde.;-))

greetz joker  

neue Sb-2/A gesehen? "Pre-effective amendment"